All 3 DNAm sites were located in the promoter region of TP53INP1 and had positive effects on the expression level of TP53INP1 and on T2D risk (Supplementary Data 8, 10, and 11). The gene discussed is TP53INP1; the disease is type 2 diabetes mellitus.